Skip to content

SCHEDULE 13GAccepted Nov 13, 5:04 PM ET

Lyell Immunopharma, Inc. SCHEDULE 13G

Innovative Cellular Therapeutics Holdings Ltd

Accepted (ET)

5:04 PM

Nov 13, 2025

Filed

Nov 13, 2025

Documents

1

Size

6.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.